
Scriptfair Medicines Private Limited
About Scriptfair Medicines Private Limited
Data last updated:
Scriptfair Medicines Private Limited was a private limited company based in Kolkata, West Bengal, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the specialised services segment of the trading and commerce sector. It was incorporated on 02 September 2021.
The company was registered with the Registrar of Companies (ROC), Kolkata, under CIN U51909WB2021PTC247662.
The company had an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It was led by directors Arindam Sengupta and Mahua Surray.
Its last annual general meeting (AGM) was held on 29 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at Urbana Tower – 4 Unit 503 Anandapur, Kolkata, West Bengal, India – 700107.
As per the financials filed for FY 2023, the company reported a revenue of ₹10.11 Lakh. For the same year it recorded a net loss of ₹79,732 (net margin -7.9%) and EBITDA of -₹79,732 (EBITDA margin -7.9%).
Company details
Contact details
Scriptfair Medicines Private Limited's registered office is in Kolkata, West Bengal.
- Registered AddressUrbana Tower – 4 Unit 503 Anandapur, Kolkata, West Bengal, India – 700107
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Scriptfair Medicines is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Scriptfair Medicines Private Limited, buy the company report.
Financials of Scriptfair Medicines Private Limited
FY 2023 filings availableScriptfair Medicines Private Limited reported revenue of ₹10.11 Lakh for FY 2023.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹79,732 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹79,732 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -7.9% | |
| Net Profit Margin | -7.9% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Scriptfair Medicines Private Limited, buy the company report.
Board of directors of Scriptfair Medicines Private Limited
Scriptfair Medicines has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arindam Sengupta | Director | 02 Sep 2021 | 5 Years 2 Months | As last reported |
| Mahua Surray Also directs: Script Infinite Services Private Limited | Director | 02 Sep 2021 | 5 Years 2 Months | As last reported |
Peer comparison
Scriptfair Medicines Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ksa Build-Materials Private Limited | ₹10.12 Lakh (FY 2025) | -28.0% | Kunnamkualm, Kerala, India | |||
| Acreland Estates Private Limited | ₹10.12 Lakh (FY 2025) | 1.0% | New Delhi, Delhi, India | |||
| Nagma Retail Solutions Private Limited | ₹10.12 Lakh (FY 2024) | 822.0% | Noida, Uttar Pradesh, India | |||
| Jai Bhawani Concast Private Limited | ₹10.12 Lakh (FY 2025) | -67.0% | Bhiwadi, Rajasthan, India | |||
| Jak Edibles India Private Limited | ₹10.12 Lakh (FY 2024) | 21.0% | Secunderabad, Telangana, India | |||
| Scriptfair Medicines Private Limitedthis company | ₹10.11 Lakh (FY 2023) | -₹79,732 | -7.9% | Kolkata, West Bengal, India | ||
| Gramin Basket Private Limited | ₹10.11 Lakh (FY 2018) | Delhi, India | ||||
| Autopumps and Bearings Company Private Limited | ₹10.11 Lakh (FY 2024) | 2.0% | Chennai, Tamil Nadu, India | |||
| Mayurpankhi Retail Private Limited | ₹10.11 Lakh (FY 2024) | Allahabad, Uttar Pradesh, India | ||||
| Sunovis Enterprises Private Limited | ₹10.11 Lakh (FY 2018) | -41.0% | New Delhi, Delhi, India | |||
| Oriental Diesels and Engineering Company Private Limited | ₹10.11 Lakh (FY 2025) | -95.0% | Allahabad, Uttar Pradesh, India |
To see the full peer comparison of Scriptfair Medicines Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Scriptfair Medicines Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Scriptfair Medicines Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Scriptfair Medicines Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Scriptfair Medicines Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Arindam Sengupta was appointed as Director on 02 Sep 2021.
Frequently asked questions
Scriptfair Medicines has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Scriptfair Medicines was a private limited company based in Kolkata, West Bengal, India. The company worked in specialty, within the trading industry. It was incorporated on 02 September 2021 and is registered under CIN U51909WB2021PTC247662. The company has been struck off by the Registrar of Companies and is no longer operational.
Scriptfair Medicines had 2 directors:
- Arindam Sengupta - Director
- Mahua Surray - Director
The CIN (Corporate Identification Number) of Scriptfair Medicines is U51909WB2021PTC247662. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Scriptfair Medicines is at Urbana Tower – 4 Unit 503 Anandapur, Kolkata, West Bengal, India – 700107.
Scriptfair Medicines was incorporated on 02 September 2021. It is registered with the Registrar of Companies, Kolkata.
The latest financial statements of Scriptfair Medicines on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 29 September 2023. Year-wise statements from FY 2022 are in the company report.
Scriptfair Medicines operated in the trading industry, in the specialty segment. It worked in this industry before it was struck off.
The peers of Scriptfair Medicines by revenue are Ksa Build-Materials Private Limited, Acreland Estates Private Limited, Nagma Retail Solutions Private Limited, Jai Bhawani Concast Private Limited, Jak Edibles India Private Limited and 5 more, all in the same principal business activity (retail trading).
Arindam Sengupta was appointed as Director on 02 Sep 2021. Mahua Surray was appointed as Director on 02 Sep 2021.
Scriptfair Medicines can be reached at its registered office: Urbana Tower – 4 Unit 503 Anandapur, Kolkata, West Bengal, India – 700107.

